TY  - JOUR
AU  - Radujkovic, Aleksandar
AU  - Becker, Natalia
AU  - Benner, Axel
AU  - Penack, Olaf
AU  - Platzbecker, Uwe
AU  - Stölzel, Friedrich
AU  - Bornhäuser, Martin
AU  - Hegenbart, Ute
AU  - Ho, Anthony D
AU  - Dreger, Peter
AU  - Luft, Thomas
TI  - Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome.
JO  - OncoTarget
VL  - 6
IS  - 33
SN  - 1949-2553
CY  - [S.l.]
PB  - Impact Journals LLC
M1  - DKFZ-2017-03371
SP  - 7406-7420
PY  - 2015
AB  - Allogeneic stem cell transplantation (alloSCT) represents a curative therapeutic option for patients with myelodysplastic syndrome (MDS), but relapse and non-relapse mortality (NRM) limit treatment efficacy. Based on our previous observation in acute myeloid leukemia we investigated the impact of pre-transplant weight loss on post-transplant outcome in MDS patients. A total of 111 patients diagnosed with MDS according to WHO criteria transplanted between 2000 and 2012 in three different transplant centers were included into the analysis. Data on weight loss were collected from medical records prior to conditioning therapy and 3-6 months earlier. Patient, disease and transplant characteristics did not differ between patients with weight loss (2-5
LB  - PUB:(DE-HGF)16
C6  - pmid:26360778
C2  - pmc:PMC4741512
DO  - DOI:10.18632/oncotarget.4805
UR  - https://inrepo02.dkfz.de/record/127346
ER  -